UncategorizedModulo Bio lands $4.8m ADDF investment to advance dementia drug Empower Meds / November 23, 2025
UncategorizedAeon Clinic unveils next-gen medicine at 2025 masterclass in Dubai – Longevity.Technology Empower Meds / November 23, 2025
UncategorizedAlnylam’s AMVUTTRA wins FDA nod for ATTR-related heart disease Empower Meds / November 23, 2025
UncategorizedNewLimit restores ‘youthful function’ to liver and immune cells Empower Meds / November 23, 2025
UncategorizedSRW supplement shows biological age reduction in 12-month study Empower Meds / November 23, 2025
UncategorizedAugustine Therapeutics lands $85m to advance HDAC6 inhibitors for chronic diseases Empower Meds / November 23, 2025
UncategorizedHLI makes $1m prostate cancer prevention pledge to each member Empower Meds / November 23, 2025
UncategorizedFountain Life opens fifth diagnostic center in Houston, Texas – Longevity.Technology Empower Meds / November 23, 2025
UncategorizedUNITY Biotech reveals topline results from senolytic DME trial Empower Meds / November 23, 2025
